GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.43X leverage
Performance
- Low
- ₹1,911
- High
- ₹1,969
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹1,969
- Previous Close₹1,969
- Volume490,999
- 50 DMA₹1,974.70
- 100 DMA₹1,948.40
- 200 DMA₹1,860.59
Investment Returns
- Over 1 Month -6.74%
- Over 3 Month + 6.87%
- Over 6 Month -4.48%
- Over 1 Year + 29%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 51.3
- PEG Ratio
- 0.1
- Market Cap Cr
- 54,600
- P/B Ratio
- 5.7
- Average True Range
- 59.19
- EPS
- 95.92
- Dividend Yield
- 0.3
- MACD Signal
- -7.4
- RSI
- 43.29
- MFI
- 26.66
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,934.80
-34.5
(-1.75%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹1,975.23
- 50 Day
- ₹1,974.70
- 100 Day
- ₹1,948.40
- 200 Day
- ₹1,860.59
Resistance and Support
1938.37
- R3 2,024.03
- R2 1,996.67
- R1 1,965.73
- S1 1,907.43
- S2 1,880.07
- S3 1,849.13
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,934 As on 07 February, 2026 | 16:29
The Market Cap of Glenmark Pharmaceuticals is ₹54600.2 Cr As on 07 February, 2026 | 16:29
The P/E ratio of Glenmark Pharmaceuticals is 51.3 As on 07 February, 2026 | 16:29
The PB ratio of Glenmark Pharmaceuticals is 5.7 As on 07 February, 2026 | 16:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.